S
TERN

SignatureFD’s Terns Pharmaceuticals TERN Stock Holding History

SignatureFD’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-353
Closed -$18.6K – 3634
2026
Q1 		$18.6K Buy
353
+331
+1,505% +$13.6K ﹤0.01% 2228
2025
Q4 		$889 Buy
+22
New +$508 ﹤0.01% 3140
2025
Q1 		– Sell
-376
Closed -$2.08K – 3443
2024
Q4 		$2.08K Buy
376
+53
+16% +$359 ﹤0.01% 2854
2024
Q3 		$2.69K Buy
323
+224
+226% +$1.84K ﹤0.01% 2749
2024
Q2 		$674 Hold
99
– – ﹤0.01% 2953
2024
Q1 		$649 Sell
99
-754
-88% -$4.92K ﹤0.01% 3003
2023
Q4 		$5.54K Buy
853
+186
+28% +$983 ﹤0.01% 2469
2023
Q3 		$3.35K Buy
667
+410
+160% +$2.6K ﹤0.01% 2625
2023
Q2 		$2.25K Buy
257
+154
+150% +$1.79K ﹤0.01% 2772
2023
Q1 		$1.22K Buy
+103
New +$984 ﹤0.01% 2938
2021
Q3 		– Sell
-60
Closed -$1K – 3207
2021
Q2 		$1K Buy
+60
New +$1.02K ﹤0.01% 2835

Other funds holding TERN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

SignatureFD's TERN Position: Q2 2026 in Review

SignatureFD sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 353 shares — an estimated $18.6K sold.

SignatureFD first reported a position in TERN in Q2 2021 and held it in 11 quarters. The position peaked at $18.6K in Q1 2026. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

  • SignatureFD reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • SignatureFD sold 353 Terns Pharmaceuticals shares in Q2 2026, an estimated $18.6K.
  • SignatureFD first reported a position in Terns Pharmaceuticals in Q2 2021 and held it in 11 quarters.
  • SignatureFD's Terns Pharmaceuticals position peaked at $18.6K in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.